StonvexLoading…
StonvexStonvexStonvexCore line items from COFS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.98M | $18.99M | $13.76M | $8.47M |
Operating Income | $16.68M | $34.19M | $17.40M | $-926.00K |
Net Income | $13.70M | $28.18M | $14.31M | $-372.00K |
EPS (Diluted) | $0.91 | $2.01 | $1.05 | $-0.03 |
Total Assets | $4.39B | $4.41B | $4.30B | $4.31B |
Total Liabilities | $3.92B | $3.95B | $3.85B | $3.88B |
Cash & Equivalents | $84.22M | $87.99M | $98.98M | $156.28M |
Free Cash Flow OCF − CapEx | $-1.70M | $25.19M | $13.27M | $-424.00K |
Shares Outstanding | 14.96M | 15.00M | 15.02M | 15.01M |